-

Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer

A 30+ year industry veteran from Signify Health and Match.com, Shane joins to scale Virta’s technology platform amid triple-digit year-over-year growth

SAN FRANCISCO--(BUSINESS WIRE)--Today, diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO). With over three decades of experience at companies like Signify Health and Match.com, Shane joins to scale Virta’s technology through continued triple-digit growth and surging demand for its innovative approach to treating metabolic diseases like type 2 diabetes, prediabetes, and obesity.

Shane’s appointment coincides with a sea change in the expectations for outcomes in metabolic care. Advanced telemedicine solutions like Virta’s Continuous Remote Care platform make long-lasting lifestyle changes—in addition to disease reversal and remission—a reality.

“Virta’s technology gives our physicians and health coaches superpowers that make diabetes reversal possible,” said Sami Inkinen, Co-Founder and CEO of Virta Health. “Shane’s leadership will be crucial to deliver transformative outcomes for the 60%+ of Americans with a metabolic disease.”

Virta’s Continuous Remote Care platform—where clinicians and health coaches provide near real-time care to patients—acts on millions of data points per month to enable high degrees of personalization and proactive support for long-term adoption of Virta’s nutrition therapy. Further, this technology is essential for safe, provider-led de-prescription of medications as patients move towards reversal.

In his new role, Shane will oversee further advancement of the Continuous Remote Care platform, and lead Virta’s Engineering, Applied Artificial Intelligence/Machine Learning, and Insights and Analytics teams.

Before Virta, Shane led the technology teams as CTO at Signify Health (NYSE: SGFY), a leading healthcare platform leveraging advanced analytics, technology, and nationwide provider networks to create and power value-based payment programs. Shane also served as SVP of technology at Match.com (NASDAQ: MTCH), where he helped scale the company internationally into a billion-dollar business, founded the Match Mobile Technology Team, and created the Match.com app.

Virta’s technology team has doubled over the past 12 months alone and is actively hiring. To learn more and apply for open positions, visit www.virtahealth.com/careers.

About Virta Health:

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by nearly 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit www.virtahealth.com or follow us on Twitter @virtahealth.

Contacts

Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

Virta Health


Release Versions

Contacts

Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

More News From Virta Health

Virta Health Reduces Risk of Heart Attack, Stroke, and Death by 56%

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced new peer-reviewed research published in Cardiology and Therapy which shows members following Virta’s individualized nutrition therapy and AI-powered, continuous clinical care had a 56% lower risk of major cardiovascular events, including heart attack, stroke and death, than those receiving standard care. These results are independent of the use of medications, such as GLP-1s. Cardiovascular disease...

Virta Health Reports 37% Greater Weight Loss When GLP-1s are Paired with its AI-enabled Personalized Nutrition

DENVER--(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its 2026 Reversal Report: Metabolic Care in the GLP-1 Era with a striking finding: Virta members taking GLP-1s achieved substantially better results when medication was paired with the company’s AI-enabled, clinically supervised, personalized nutrition therapy. In a real-world analysis of more than 4,000 adults, those who followed the Virta Method™ achieved 37% greater weight loss after one year than...

Virta Health Reaches Profitability, Now Serving More Than 750 Organizations

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced its first profitable quarter, reaching a major financial milestone as demand grows for comprehensive metabolic care that delivers better health while lowering costs. Virta now serves more than 750 employers, health plans, and government organizations, helping lower their total cost of care while improving cardiometabolic health outcomes like obesity, type 2 diabetes, and cardiovascular disease. Rec...
Back to Newsroom